Paper · 23415580
Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.
Resta N and 30 others. Dig Liver Dis, 2013. Cited by 114 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study. Papers, record 23415580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23415580
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cancer risk associated with STK11/LKB1 germline mutations in Peutz-Jeghers syndrome patients: results of an Italian multicenter study.
- PubMed
Topics28
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Germ-Line Mutation | Major topic |
| Pancreatic Neoplasms | Major topic |
| Peutz-Jeghers Syndrome | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Uterine Cervical Neoplasms | Major topic |
| AMP-Activated Protein Kinase Kinases | |
| Adolescent | |
| Adult | |
| Aged | |
| Breast Neoplasms | |
| Child | |
| Child, Preschool | |
| Cohort Studies | |
| Female | |
| Gastrointestinal Neoplasms | |
| Genetic Predisposition to Disease | |
| Genital Neoplasms, Female | |
| Humans | |
| Italy | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Neoplasms | |
| Phenotype | |
| Retrospective Studies | |
| Risk Factors | |
| Sex Distribution | |
| Young Adult |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 114 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,921,048 | Expect the unexpected: cervical gastric-type adenocarcinoma in situ in a patient with long-standing Peutz-Jeghers syndrome - a case report and literature review. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42921048 | PubMed |
| 42,877,302 | Natural History of Rare Tumor Risk Syndromes: A Scoping Review to Inform Cost-Effectiveness Models. | J Health Econ Outcomes Res | 2026 | https://conductscience.org/library/papers/42877302 | PubMed |
| 42,131,318 | MicroRNA-based strategies to overcome the immunotherapy barrier in pancreatic ductal adenocarcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42131318 | PubMed |
| 42,129,295 | Follow-up, cancer risk and mortality in Peutz-Jeghers syndrome: Data from the PRED-IdF network. | Eur J Hum Genet | 2026 | https://conductscience.org/library/papers/42129295 | PubMed |
| 41,899,580 | Genetic Predisposition to Pancreatic Cancer: A Systematic Review of Hereditary Syndromes and Familial Aggregation. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41899580 | PubMed |
| 41,155,343 | HPV-Independent Cervical Cancer-A New Challenge of Modern Oncology. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155343 | PubMed |
| 41,143,909 | Clinicopathological characterization of female genital tract cancers with STK11 alterations: redefining the spectrum beyond STK11 adnexal tumors. | Virchows Arch | 2026 | https://conductscience.org/library/papers/41143909 | PubMed |
| 41,123,644 | Clinical features and endoscopic polyp management of Peutz-Jeghers syndrome: the 2nd nationwide epidemiological survey in Japan. | J Gastroenterol | 2026 | https://conductscience.org/library/papers/41123644 | PubMed |
| 40,791,513 | Comprehensively Testing the Function of Missense Variation in the STK11 Tumour Suppressor. | bioRxiv | 2025 | https://conductscience.org/library/papers/40791513 | PubMed |
| 40,673,273 | Precancerous pathways to gastric cancer: a review of experimental animal models recapitulating the correa cascade. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40673273 | PubMed |
1 to 10 of 74
See all 74 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| STK11 | 6,794 | PubTator's text mining | https://conductscience.org/library/genes/6794 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23415580
GET https://conductscience.org/api/papers/v1/23415580/authors?page=2